<page>
    <title>-xizu-</title>
    <ns>0</ns>
    <id>1668571</id>
    <revision>
      <id>82004351</id>
      <parentid>76290480</parentid>
      <timestamp>2024-09-27T12:53:27Z</timestamp>
      <contributor>
        <username>WingerBot</username>
        <id>2024159</id>
      </contributor>
      <minor />
      <comment>templatize topical categories for langcode=en using {{C}}</comment>
      <origin>82004351</origin>
      <model>wikitext</model>
      <format>text/x-wiki</format>
      <text bytes="427" sha1="20a2ly7hb8rf1hy8ihl14p4zwaeznva" xml:space="preserve">==English==

===Etymology===
From {{affix|en|-xi-|-zu-}}.

===Infix===
{{head|en|infix}}

# {{lb|en|pharmacology}} A hybrid [[monoclonal antibody]], derived from both [[chimeric]] and [[humanized]] sources.

====Derived terms====
* {{l|en|dorlixizumab}}
* {{l|en|otelixizumab}}

====Related terms====
* {{l|en|-mab}} is the base suffix common to all monoclonal antibodies. (See that entry for full paradigm.)

{{C|en|Medicine}}</text>
      <sha1>20a2ly7hb8rf1hy8ihl14p4zwaeznva</sha1>
    </revision>
  </page>